Refining Tumor Mutational Burden as a Predictive Biomarker for Pembrolizumab: A Real-World Analysis in Japanese Patients.
This study evaluated tumor mutational burden (TMB) as a real-world predictor of pembrolizumab efficacy in a large Japane...
Non-invasive screening in hereditary cancer: a randomized controlled trial to test cell-free DNA-based early detection in the CHARM consortium.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication describes the design and aims of the CHARM2 trial, a Canadian, prospective randomized controlled study...
A unified framework for pre-screening and screening tools in oncology clinical trials.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication is a narrative review of current and emerging approaches to identifying and enrolling oncology patients...
Gut microbial metabolites in cancer immunomodulation.
- Post category:Supportive Oncology
- Reading time:3 mins read
This publication is a mechanistic, translational review on how gut microbiota–derived metabolites regulate tumor immun...
Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for Expertise.
- Post category:Supportive Oncology
- Reading time:2 mins read
This publication is a Society of Nuclear Medicine and Molecular Imaging (SNMMI) position paper outlining how radiopharma...
AI-Guided SERS Defines a Pan-Cancer Diagnostic Biomarker.
- Post category:Supportive Oncology
- Reading time:1 min read
This study presents an AI-powered SERS (Surface-Enhanced Raman Scattering) chip that enables early and accurate detectio...